Cyclophosphamide, bortezomib, and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression-free survival (Q58853078)
Jump to navigation
Jump to search
article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cyclophosphamide, bortezomib, and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression-free survival |
article |
Statements
Cyclophosphamide, bortezomib, and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression-free survival (English)
Christopher P Venner
Thirusha Lane
Darren Foard
Lisa Rannigan
Simon D J Gibbs
Jennifer H Pinney
Carol J Whelan
Julian D Gillmore
Philip N Hawkins
Ashutosh D Wechalekar
13 February 2012